Date of CRT 2018 Already Confirmed

The annual event reuniting more than 2500 endovascular specialists and interventionists will be held on March 3 to 6, 2018, in Washington D.C. 

CRT Congress

CRT is one of the most important meetings of interventional cardiology in the world. This event is held every year at the Omni Shoreham Hotel in Washington DC. CRT offers attendees a great opportunity to share ideas and knowledge, collaborate with percutaneous intervention solutions, receive training on interventional cardiology and get in touch with other professionals. Our meeting offers sessions focused on education and training and show the latest, most advanced techniques, which can be applied directly to clinical and academical practices.

 

With more than 2500 attendees, the CRT meeting continues to be a leading endovascular and interventional cardiology boutique. The MedStar Heart & Vascular Institute supports CRT as a forum for physicians aimed at training health care professionals on new cardiovascular technology and intervention procedures. This event on interventional cardiology is organized in four days full of value, with talks, presentations, workshops, symposia, poster sessions and discussions with top interventional and structural cardiology specialists. 

You cannot miss this long-awaited annual meeting on interventional cardiology!

Look at the preliminary program

More information 

More articles by this author

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

SELUTION Sirolimus-Eluting Balloon For De Novo Coronary Lesions – New Evidence and Clinical Perspectives

The Latin American Society of Interventional Cardiology invites you to join a new virtual scientific event focused on the latest evidence and clinical perspectives...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...